No one should face hereditary cancer alone.

Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.

Hereditary Cancer Info > Risk Management > Breast Cancer Chemoprevention


BRCA & HBOC
Toggle Menu

Breast Cancer Chemoprevention

Learn about the steps that people at high risk for cancer can take to manage their risk and protect their health.

Tamoxifen

Tamoxifen is a Selective Estrogen Receptor Modulator (SERM), one of a group of drugs that block the effect of estrogen on breast tissue. Tamoxifen is approved for use in both pre- and post-menopausal women. When taken for five years, it reduces breast cancer risk by up to 40%; this protective effect continues beyond the five-year treatment period. Based on this evidence, five years of tamoxifen is now recommended to reduce the risk of breast cancer in  high-risk women. 

Tamoxifen offers additional benefits beyond treatment. In studies of BRCA mutation carriers who were diagnosed with cancer in one breast and took tamoxifen, the risk for breast cancer in their healthy breast was reduced by up to 50%; this protective effect occurred even among BRCA1 mutation carriers who tended to develop ER-negative disease. Tamoxifen may also protect bone density and reduce osteoporosis risk in postmenopausal women who cannot take hormone replacement therapy. Side effects of tamoxifen include an increased risk of endometrial cancer and blood clots.

High-risk women who wish to consider tamoxifen to lower their risk for breast cancer should discuss the benefits, risks and limitations with their health care providers.

Updated 03/31/2019

FORCE:Facing Our Risk of Cancer Empowered